<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04345926</url>
  </required_header>
  <id_info>
    <org_study_id>OAIC 938/18</org_study_id>
    <nct_id>NCT04345926</nct_id>
  </id_info>
  <brief_title>Dose-response Curves Between Propofol and Intraoperative Electroencephalographic Patterns</brief_title>
  <official_title>Determination of Dose-response Curves Between Propofol Concentration and Intraoperative Electroencephalographic Patterns Until Burst Suppression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chile</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Chile</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the world, 230 million surgeries are performed per year and a significant part is&#xD;
      performed in patients over 65 years of age. These patients are more labile, especially from&#xD;
      the neurocognitive point of view with a high risk to develop neurocognitive complications,&#xD;
      such as postoperative delirium. Recent studies have linked this type of complication with an&#xD;
      overdose of general anesthetics during surgery. For this reason, in recent years, the use of&#xD;
      brain function monitors during the intraoperative period has been recommended to adapt the&#xD;
      dosage of the drugs to each patient and thus to avoid overdosing of general anesthetics.&#xD;
      However, to date, the available monitors that process the electroencephalographic signal are&#xD;
      not able to adequately discriminate gradual changes in anesthetic depth. Also, no systematic&#xD;
      studies have been performed that analyze changes that occur in the electroencephalogram (EEG)&#xD;
      signal secondary to increases in complications from general anesthetics. Thus, the&#xD;
      investigators design this study with the main aim to determine the changes in&#xD;
      electroencephalographic patterns induced by a stepped increase of propofol until the burst&#xD;
      suppression is reached.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will carry out a prospective analytical observational clinical study at the&#xD;
      Clinical Hospital of the University of Chile. In total 15 patients will be recruited, in who&#xD;
      a frontal electroencephalographic signal will be recorded using a SedLine® monitor, and&#xD;
      propofol concentration will be estimated using the Marsh model. First, the concentration of&#xD;
      propofol at the loss of consciousness (LOS) will be recorded in the presence of remifentanil&#xD;
      (7.5 ng/mL). Then, patients will be intubated and remifentanil will be decreased to 4 ng/mL.&#xD;
      After that, the concentration of propofol that caused the LOS will be maintained for 20&#xD;
      minutes. Finally, propofol will be increased in steps of 0.3 mcg/mL for 7 min, until an&#xD;
      episode of burst suppression will be observed. In the complete protocol, EEG activity will be&#xD;
      acquired using a SedLine® monitor.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 16, 2018</start_date>
  <completion_date type="Actual">February 26, 2020</completion_date>
  <primary_completion_date type="Actual">February 26, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the alpha power of EEG Spectrogram</measure>
    <time_frame>Change between baseline time (0 minutes) and burst suppression time (35 minutes)</time_frame>
    <description>% of change</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the delta power of EEG Spectrogram</measure>
    <time_frame>Change between baseline time (0 minutes) and burst suppression time (35 minutes)</time_frame>
    <description>% of change</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the coherence</measure>
    <time_frame>Change between baseline time (0 minutes) and burst suppression time (35 minutes)</time_frame>
    <description>% of change</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the propofol concentration</measure>
    <time_frame>Change between baseline time (0 minutes) and burst suppression time (35 minutes)</time_frame>
    <description>concentration in mcg/mL</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Propofol Overdose</condition>
  <condition>EEG</condition>
  <arm_group>
    <arm_group_label>Dose-response</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>- Concentration of propofol at the loss of consciousness (LOS) will be recorded in the presence of remifentanil (7.5 ng/mL) (LOS time).&#xD;
- Patients will be intubated and remifentanil will be decreased to 4 ng/mL.&#xD;
- Concentration of propofol that caused the LOS will be maintained for 20 minutes (Baseline time).&#xD;
- Propofol will be increased in steps of 0.3 mcg/mL for 7 minutes until an episode of burst suppression will be observed (Burst suppression time).&#xD;
EEG activity will be acquired using a SedLine® monitor during the complete protocol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Stepped propofol concentration after 20 min of LOS</description>
    <arm_group_label>Dose-response</arm_group_label>
    <other_name>Dosage increase</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electroencephalogram recording</intervention_name>
    <description>Acquisition of EEG activity</description>
    <arm_group_label>Dose-response</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) Physical Status 1 or 2&#xD;
&#xD;
          -  Low-risk surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  BMI &gt; 35 kg/m2&#xD;
&#xD;
          -  Benzodiazepines use&#xD;
&#xD;
          -  Epilepsy&#xD;
&#xD;
          -  Psychiatric disorder&#xD;
&#xD;
          -  Kidney disease&#xD;
&#xD;
          -  Liver disease&#xD;
&#xD;
          -  Brain damage&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose I Egaña, MD/PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Felipe Maldonado, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rodrigo Gutierrez, MD/PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonello Penna, MD/PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chile</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centro de Investigación Cínica Avanzada (CICA), Hospital Clinico de la Universidad de Chile</name>
      <address>
        <city>Santiago</city>
        <state>RM</state>
        <zip>7690306</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico de la Universidad de Chile</name>
      <address>
        <city>Santiago</city>
        <state>RM</state>
        <zip>7690306</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 7, 2020</study_first_submitted>
  <study_first_submitted_qc>April 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2020</study_first_posted>
  <last_update_submitted>April 26, 2021</last_update_submitted>
  <last_update_submitted_qc>April 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Chile</investigator_affiliation>
    <investigator_full_name>Antonello Penna</investigator_full_name>
    <investigator_title>Principal Investigator, Anesthesiologist, MD-PhD</investigator_title>
  </responsible_party>
  <keyword>Propofol</keyword>
  <keyword>General anesthesia</keyword>
  <keyword>EEG</keyword>
  <keyword>Burst suppression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Drug Overdose</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

